Pulmatrix, Inc. (PULM) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Pulmatrix, Inc. on October 3, 2024. The filing addresses corporate governance matters regarding the scheduling of the 2024 Annual Meeting of Stockholders and the deadlines for shareholder proposals and director nominations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance notifications and does not contain financial performance data.
Material Changes
The primary material change disclosed is the rescheduling of the 2024 Annual Meeting of Stockholders. The meeting is now set for Wednesday, December 18, 2024. This date represents a change of more than 30 days from the anniversary of the 2023 Annual Meeting, triggering specific notification requirements for shareholder proposals.
Guidance, Outlook, and Management Commentary
Management has established the record date for the 2024 Annual Meeting as the close of business on October 31, 2024. The filing outlines strict deadlines for shareholders wishing to submit proposals or nominate directors:
- Rule 14a-8 Proposals: Must be received by the Corporate Secretary by October 18, 2024.
- Bylaw Proposals and Director Nominations: Written notice must be received by the Chief Executive Officer by October 18, 2024.
- Universal Proxy Solicitations: Notice required by October 18, 2024.
The filing does not contain financial guidance, risk factors, or discussion of unusual items.
Key Facts for Investor Verification
- Annual Meeting Date: December 18, 2024.
- Record Date: October 31, 2024.
- Proposal Deadline: October 18, 2024 (for both Rule 14a-8 and Bylaw proposals).
- Leadership: The report was signed by Peter Ludlum, Interim Chief Executive Officer and Interim Chief Financial Officer.
- Financial Data: No financial metrics are disclosed in this specific filing; investors should refer to the most recent 10-Q or 10-K for financial status.